Anticorps Polyclonal de lapin anti-Phospho-eNOS (Thr495)
Phospho-eNOS (Thr495) Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (2)
Applications
WB, ELISA
Conjugaison
Non conjugué
N° de cat : 28939-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HUVEC traitées au VEGF, cellules HUVEC traitées à l'EGF, cellules HUVEC traitées au chlorure de cobalt |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 7 publications below |
Informations sur le produit
28939-1-AP cible Phospho-eNOS (Thr495) dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | rat, Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | Peptide |
| Nom complet | nitric oxide synthase 3 (endothelial cell) |
| Masse moléculaire calculée | 133 kDa |
| Poids moléculaire observé | 140 kDa |
| Numéro d’acquisition GenBank | BC063294 |
| Symbole du gène | eNOS |
| Identification du gène (NCBI) | 4846 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Endothelial NOS (eNOS), also known as nitric oxide synthase 3 (NOS3), has a protective function in the cardiovascular system, which is attributed to NO production. Polymorphisms in NOS3 gene affects the susceptibility to several diseases such as hypertension, preeclampsia, diabetes mellitus, obesity, erectile dysfunction, and migraine. The sequence homology of eNOS protein in human and mouse is above 90%, and phosphorylation of threonine at 495 site in human corresponds to 494 site in mouse.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for Phospho-eNOS (Thr495) antibody 28939-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Hypertension Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia | ||
Commun Biol Targeting GPR39 in structure-based drug discovery reduces Ang II-induced hypertension | ||
J Ethnopharmacol Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via MK/integrin signaling pathway | ||
Drug Des Devel Ther Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157. | ||
J Oncol Hax-1 Regulates Radiation-Induced Mitochondrial-Dependent Apoptosis of Uveal Melanoma Cells through PI3K/AKT/eNOS Pathway. | ||
Cytotherapy Porous gelatin microspheres implanted with adipose mesenchymal stromal cells promote angiogenesis via protein kinase B/endothelial nitric oxide synthase signaling pathway in bladder reconstruction |
